VPIM
SRPT icon

Vanguard Personalized Indexing Management’s Sarepta Therapeutics SRPT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,176
Closed -$394K – 2030
2025
Q1 		$394K Sell
6,176
-1,532
-20% -$161K 0.01% 1223
2024
Q4 		$937K Buy
7,708
+1,919
+33% +$235K 0.01% 801
2024
Q3 		$723K Buy
5,789
+1,284
+29% +$178K 0.01% 921
2024
Q2 		$712K Buy
4,505
+479
+12% +$61.5K 0.01% 849
2024
Q1 		$521K Buy
4,026
+365
+10% +$44.7K 0.01% 1002
2023
Q4 		$353K Sell
3,661
-2,469
-40% -$237K 0.01% 1164
2023
Q3 		$743K Sell
6,130
-30
-0.5% -$3.39K 0.02% 710
2023
Q2 		$705K Sell
6,160
-111
-2% -$14.3K 0.02% 745
2023
Q1 		$864K Sell
6,271
-125
-2% -$16.2K 0.03% 602
2022
Q4 		$829K Buy
6,396
+518
+9% +$60K 0.03% 582
2022
Q3 		$650K Buy
5,878
+69
+1% +$6.96K 0.03% 675
2022
Q2 		$435K Sell
5,809
-2,023
-26% -$149K 0.02% 864
2022
Q1 		$612K Sell
7,832
-2,945
-27% -$226K 0.03% 728
2021
Q4 		$970K Buy
+10,777
New +$921K 0.06% 408

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Vanguard Personalized Indexing Management's SRPT Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 6,176 shares — an estimated $394K sold.

Vanguard Personalized Indexing Management first reported a position in SRPT in Q4 2021 and held it in 14 quarters. The position peaked at $970K in Q4 2021. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 6,176 Sarepta Therapeutics shares in Q2 2025, an estimated $394K.
  • Vanguard Personalized Indexing Management first reported a position in Sarepta Therapeutics in Q4 2021 and held it in 14 quarters.
  • Vanguard Personalized Indexing Management's Sarepta Therapeutics position peaked at $970K in Q4 2021.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.